Stay updated with breaking news from Celularity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The stem cell umbilical cord blood (UCB) market has been segmented by end-user (pharmaceutical, research institutes, hospitals, and biobanks)...
Global Stem Cell Umbilical Cord Blood (UCB) Market 2022-2026 The analyst has been monitoring the stem cell umbilical cord blood (UCB) market and it is...
Celularity named Dr. Adrian Kilcoyne as EVP, chief medical officer and head of global medical affairs, patient safety and patient affairs.
Veteran pharmaceutical executive brings more than 15 years of proven oncology and immunology experience...
/PRNewswire/ -- Immunis Inc., a private biotechnology company developing an immunomodulatory secretome for age and disease-related immune decline in Phase 1/2a...